Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3251
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00513097 | Curbing Tobacco Use in Suburban and Rural Schools | ||
| NCT03465774 | Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions | ||
| NCT00455559 | Ph II Study of Perifosine Plus Gleevec for Patients With GIST | ||
| NCT03856060 | Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits | ||
| NCT01094860 | Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies | ||
| NCT00041782 | Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients | ||
| NCT06575374 | Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell | ||
| NCT07116486 | A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma | ||
| NCT02698254 | Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy | ||
| NCT00465179 | Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer | ||
| NCT00866346 | PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation | ||
| NCT07076186 | Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS | ||
| NCT01087983 | Lapatinib With Sirolimus or Metformin | ||
| NCT01333423 | Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC) | ||
| NCT00968396 | Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts | ||
| NCT00513162 | Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases | ||
| NCT03259503 | Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant | ||
| NCT00503256 | Genetic Study of Chronic Lymphocytic Leukemia Families | ||
| NCT02684162 | Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant | ||
| NCT04185337 | Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes | ||
| NCT04973683 | AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer | ||
| NCT00003245 | Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma | ||
| NCT02392039 | Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma | ||
| NCT00868595 | MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer | ||
| NCT00508339 | Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients | ||
| NCT03844620 | Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer | ||
| NCT05007873 | ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase | ||
| NCT07162480 | Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I) | ||
| NCT00528762 | Mexican and African American Family Focus Groups on Puberty | ||
| NCT01266603 | High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI | ||
| NCT00505869 | A Mood Management Intervention for Pregnant Smokers | ||
| NCT02159872 | Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure | ||
| NCT03941769 | 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II | ||
| NCT02543294 | REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial) | ||
| NCT00418951 | Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections | ||
| NCT01182766 | New Treatment for Alcohol and Nicotine Dependence | ||
| NCT01087554 | Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer | ||
| NCT00800566 | Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL) | ||
| NCT04810052 | Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers | ||
| NCT04774744 | Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia | ||
| NCT02760849 | Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations | ||
| NCT03698552 | ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia | ||
| NCT02949726 | Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development | ||
| NCT00502411 | Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma | ||
| NCT01409187 | IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | ||
| NCT00876499 | Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients | ||
| NCT00290498 | Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger | ||
| NCT06434363 | Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders | ||
| NCT00936858 | RAD001 for Patients With Radioiodine Refractory Thyroid Cancer | ||
| NCT02316834 | Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
